查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433292

2023-2030 年全球病患登记软体市场

Global Patient Registry Software Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 175 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内（2023-2030 年），全球病患登记软体市场将以 8.6% 的CAGR成长。该市场的成长归功于全球以患者为中心的照护。除了患者倡导团体的参与之外，纳入患者报告的结果测量也反映了以患者为中心的护理日益增长的趋势。这一转变得到了患者登记软体的帮助，该软体捕捉患者的观点和经验。根据美国国立卫生研究院的数据，2023 年 5 月，患者登记涵盖了广泛的疾病领域，其中重点是欧洲。 92%的登记处纳入了临床患者，81%的登记处获得了知情同意，76%的登记处保护了收集到的资料。 57% 的註册中心收集了患者报告的结果指标，38% 在註册中心设计过程中咨询了 PAG，51% 报告了品质管理细节，46% 报告了维护细节。

细分市场前景

全球患者登记软体市场按登记类型、软体类型、部署和最终用户进行细分。根据註册类型，市场分为特定疾病註册、健康服务註册和产品註册。根据软体类型，市场分为独立软体和整合软体。根据部署，市场分为本地和云端。此外，根据最终用户，市场又细分为医院和卫生系统、政府组织和第三方管理机构 (TPA)、製药、生物技术和医疗器材公司等。政府组织和第三方管理机构 (TPA) 子类别预计将占据最终用户细分市场的很大一部分市场份额。这归因于製药、生物技术和医疗器材公司数量的增加，这主要是由于对製药和生物技术产品的需求增加。

预计特定疾病登记子细分市场将在全球病患登记软体市场中占据相当大的份额

在註册类型中，特定疾病註册细分市场预计将在全球患者註册软体市场中占据相当大的份额。根据 BMC 的说法，2022 年 4 月，疾病登记系统是一个用于收集、分析和报告特定人群患有相同病症的患者资料的资讯系统。它可用于医疗保健评估、发病率和盛行率估计、监测护理品质、提供回馈、观察疾病的自然病程、监测临床安全性以及评估疾病负担、健康结果和成本。

区域展望

全球病患登记软体市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于慢性病的严重流行以及该地区进行的治疗手术数量的增加，预计北美将在全球市场中占据显着份额。

欧洲地区全球病患登记软体市场预计将以显着的CAGR成长

在所有地区中，欧洲地区预计在预测期内将以相当大的CAGR成长。区域增长归因于该地区罕见疾病宣传的不断加强。对罕见疾病宣传和认识的日益重视凸显了孤儿病患者未得到满足的医疗需求。患者登记处透过收集有关患者体验的真实资料来帮助实现这些目标。根据 Frontiers 报道，2022 年 8 月，欧洲药品管理局 (EMA) 评估的所有上市许可申请中，有 26.8% 涉及所谓的孤儿药产品，这些产品旨在治疗、预防或促进诊断生命性疾病。- 具有威胁性或慢性衰弱性，但在欧盟(EU)，盛行率低于万分之五。由于患者群体小且异质性，这些药物往往受到有限的临床证据的影响，而患者登记已被确定为应对这一挑战并提供资料以支持监管决策的潜在方法。病患登记是一个有组织的系统，用于收集和组织患有某种疾病、状况或暴露的人群的特定健康结果的资料。

市场参与者展望

服务全球病患登记软体市场的主要公司包括 Dacima Software, Inc.、DSG, Inc.、FIGmd Inc.、Global Vision Technologies Image Trend Inc.、LexisNexis group、IBM Corp. 等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2022 年 4 月，Quantori, LLC 推出了註册科学实务。重点是为患者、医生和研究人员开发註册计划。登记科学是医学资讯学和生物统计学的新兴领域，它将医学和流行病学结合起来，追踪长期健康结果并改善实证护理服务。

报告涵盖：

  • 2022年市场价​​值资料分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 在全球病患登记软体市场中营运的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Apixo, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • ArborMetrix
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Cerner Corp.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按登记类型分類的全球病患登记软体市场
    • 特定疾病登记处
    • 健康服务登记处
    • 产品註册
  • 按软体类型分類的全球病患登记软体市场
    • 独立软体
    • 整合软体
  • 全球病患登记软体市场（按部署）
    • 本地部署
    • 云
  • 全球病患登记软体市场（按最终使用者）
    • 医院和卫生系统
    • 政府组织和第三方管理员 (TPA)
    • 製药、生技和医疗器材公司
    • 其他（学术和研究机构、健康保险提供者）

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Dacima Software, Inc.
  • DSG, Inc.
  • FIGmd Inc.
  • Global Vision TechnologiesImage Trend Inc.
  • Health Catalyst
  • IBM Corp.
  • IQVIA Inc.
  • Liaison Technology Group
  • McKesson Corp.
  • Open Text Corp.
  • Optum, Inc.
  • Ordinal Data, Inc.
  • Syneos Health
  • Velos Inc.
Product Code: OMR2027928

Global Patient Registry Software Market Size, Share & Trends Analysis Report by Type of Registry (Disease-Specific Registries, Health Service Registries, and Product Registries), by Type of Software (Stand-Alone Software, and Integrated Software), by Deployment (On-Premises, and Cloud), and by End-User (Hospitals and Health Systems, Government Organizations, and Third Party Administrators (TPAs), Pharmaceutical, Biotechnology, and Medical Device Companies, and Others) Forecast Period (2023-2030)

The global patient registry software market is anticipated to grow at a CAGR of 8.6% during the forecast period (2023-2030). The market's growth is attributed to patient-centered care across the globe. The inclusion of patient-reported outcome measures, in addition to the participation of patient advocacy groups, reflects an increasing tendency toward patient-centered care. This transition is aided by patient registry software, that captures patient viewpoints and experiences. According to the National Institute of Health, in May 2023,patient registries covered a wide range of disease areas, with a focus on Europe. 92% of the registries included clinical patients, 81% obtained informed consent, and 76% protected the collected data. 57% of the registries collected patient-reported outcome measures, 38% consulted PAGs during the registry design process, 51% reported quality management details, and 46% reported maintenance details.

Segmental Outlook

The global patient registry software market is segmented on the type of registry, type of software, deployment, and end user. Based on the type of registry, the market is sub-segmented into disease-specific registries, health service registries, and product registries. Based on the type of software, the market is sub-segmented into stand-alone software, and integrated software. Based on the deployment, the market is sub-segmented into on-premises, and cloud. Further, on the basis of end-user, the market is sub-segmented into hospitals and health systems, government organizations and third-party administrators (TPAs), pharmaceutical, biotechnology, and medical device companies, and others. The government organizations and third party administrators (TPAs) subcategory is expected to capture a significant portion of the market share within the end-user segment. This is attributed to the number of pharmaceutical, biotechnology, and medical device companies has increased, owing essentially to increased demand for pharmaceutical and biotechnology products.

The Disease-specific Registries Sub-Segment is Anticipated to Hold a Considerable Share of the Global Patient Registry Software Market

Among the type of registry, the disease-specific registries sub-segment is expected to hold a considerable share of the global patient registry software market. According to the BMC, in April 2022, a disease registry system is an information system used for collecting, analyzing, and reporting data about a certain population of patients with the same condition. It can be used for healthcare evaluation, estimation of incidence and prevalence, monitoring the quality of care, providing feedback, observing the natural course of diseases, monitoring clinical safety, and assessing disease burden, health outcomes, and costs.

Regional Outlook

The global patient registry software market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the significant prevalence of chronic diseases, in addition to an increase in the number of therapeutic operations conducted in the region.

The Europe Region is Expected to Grow at a Significant CAGR in the Global Patient Registry Software Market

Among all regions, the Europe regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising rare disease advocacy in the region. The growing emphasis on rare disease advocacy and awareness has highlighted to light the unmet medical requirements of patients suffering from orphan diseases. Patient registries help to accomplish these objectives by collecting real-world data on patient experiences. According to the Frontiers, in August 2022, 26.8% of all the marketing authorization applications assessed by the European Medicines Agency (EMA) were for so-called orphan medicinal products, that are meant to treat, prevent or facilitate diagnosis of diseases that are life-threatening or chronically debilitating, but have a prevalence of less than 5 in 10,000 in the European Union (EU). These medicines are often subject to limited clinical evidence owing to their small and heterogeneous patient populations, and patient registries have been identified as a potential way to address this challenge and provide data to support regulatory decision-making. A patient registry is an organized system that collects and organizes data on specified health outcomes for a population with a certain disease, condition or exposure.

Market Players Outlook

The major companies serving the global patient registry software market include Dacima Software, Inc., DSG, Inc., FIGmd Inc., Global Vision Technologies Image Trend Inc., LexisNexis group, IBM Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, Quantori, LLC, launched a Registry Science Practice. That focused on the development of registry programs for patients, physicians, and researchers. Registry Science is an emerging area of medical informatics and biostatistics that combines medicine and epidemiology to track long-term health outcomes and improve evidence-based care delivery.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global patient registry software market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Apixo, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. ArborMetrix
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Cerner Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Patient Registry Software Market by Type of Registry
    • 4.1.1. Disease-specific Registries
    • 4.1.2. Health Service Registries
    • 4.1.3. Product Registries
  • 4.2. Global Patient Registry Software Market by Type of Software
    • 4.2.1. Stand-alone Software
    • 4.2.2. Integrated Software
  • 4.3. Global Patient Registry Software Market by Deployment
    • 4.3.1. On-Premises
    • 4.3.2. Cloud
  • 4.4. Global Patient Registry Software Market by End-User
    • 4.4.1. Hospitals and Health Systems
    • 4.4.2. Government Organizations and Third Party Administrators (TPAs)
    • 4.4.3. Pharmaceutical, Biotechnology, and Medical Device Companies
    • 4.4.4. Others (Academic and Research Institutions, and Health Insurance Providers)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Dacima Software, Inc.
  • 6.2. DSG, Inc.
  • 6.3. FIGmd Inc.
  • 6.4. Global Vision TechnologiesImage Trend Inc.
  • 6.5. Health Catalyst
  • 6.6. IBM Corp.
  • 6.7. IQVIA Inc.
  • 6.8. Liaison Technology Group
  • 6.9. McKesson Corp.
  • 6.10. Open Text Corp.
  • 6.11. Optum, Inc.
  • 6.12. Ordinal Data, Inc.
  • 6.13. Syneos Health
  • 6.14. Velos Inc.

LIST OF TABLES

  • 1. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY, 2022-2030 ($ MILLION)
  • 2. GLOBAL DISEASE-SPECIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL HEALTH SERVICE PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL PRODUCT PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
  • 6. GLOBAL STAND-ALONE SOFTWARE PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL INTEGRATED SOFTWARE PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 9. GLOBAL PATIENT REGISTRY SOFTWARE BASED ON-PREMISES RESEARCH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL PATIENT REGISTRY SOFTWARE BASED ON CLOUD REVIEW AND MANAGEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 12. GLOBAL PATIENT REGISTRY SOFTWARE FOR HOSPITALS AND HEALTH SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL PATIENT REGISTRY SOFTWARE FOR GOVERNMENT ORGANIZATIONS AND THIRD PARTY ADMINISTRATORS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL PATIENT REGISTRY SOFTWARE FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL PATIENT REGISTRY SOFTWARE FOR OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT , 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 22. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY, 2022-2030 ($ MILLION)
  • 24. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
  • 25. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 26. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 27. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 28. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY , 2022-2030 ($ MILLION)
  • 29. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
  • 30. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
  • 31. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 33. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY , 2022-2030 ($ MILLION)
  • 34. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
  • 35. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT , 2022-2030 ($ MILLION)
  • 36. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY TYPE OF REGISTRY, 2022 VS 2030 (%)
  • 2. GLOBAL DISEASE-SPECIFIC PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL HEALTH SERVICE PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PRODUCT PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY TYPE OF SOFTWARE, 2022 VS 2030 (%)
  • 6. GLOBAL DISEASE-SPECIFIC PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL HEALTH SERVICE RESPITE PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL PRODUCT RESPITE PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY DEPLOYMENT, 2022 VS 2030 (%)
  • 10. GLOBAL PATIENT REGISTRY SOFTWARE BASED ON-PREMISES RESEARCH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL PATIENT REGISTRY SOFTWARE BASED ON CLOUD REVIEW AND MANAGEMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 13. GLOBAL PATIENT REGISTRY SOFTWARE FOR HOSPITALS AND HEALTH SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL PATIENT REGISTRY SOFTWARE FOR GOVERNMENT ORGANIZATIONS AND THIRD PARTY ADMINISTRATORS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL PATIENT REGISTRY SOFTWARE FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL PATIENT REGISTRY SOFTWARE FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. US PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. CANADA PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. UK PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. FRANCE PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. GERMANY PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. ITALY PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. SPAIN PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. INDIA PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. CHINA PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. JAPAN PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)